期刊文献+

耐药结核产生的危险因素分析 被引量:2

Analysis of risk factors of drug resistant tuberculosis produced
下载PDF
导出
摘要 目的:分析耐药结核产生的危险因素。方法:在相关部门提取一些患者反复就诊治疗的病例,并利用调查问卷调查耐药结核病产生的危险因素。结果:耐药结核产生的危险因素主要是患者身体情况以及患者未按照医嘱护理等。结论:应该加强对耐药结核产生的危险因素的探讨,并尽早制定出可以实施的建议。 Objective:To explore the risk factors of drug resistant tuberculosis produced.Methods:We collected some patients with repeated medical treatment in the relevant departments,and investigated the risk factors of drug resistant tuberculosis produced by using questionnaire.Results:The main risk factors of drug resistant tuberculosis produced were the body condition and the patient without in accordance with the doctor of nursing and so on.Conclusion:We should strengthen the study of risk factors for drug resistant tuberculosis produced,and as soon as possible develop the practical suggestion.
作者 黄永志
机构地区 百色市人民医院
出处 《中国社区医师》 2015年第17期12-12,14,共2页 Chinese Community Doctors
关键词 耐药结核 结核 危险因素 Drug resistant tuberculosis Tuberculosis Risk factors
  • 相关文献

参考文献4

二级参考文献22

  • 1郝阳.我国结核病防治概况与今后工作设想[J].中华结核和呼吸杂志,2004,27(7):433-434. 被引量:96
  • 2结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:799
  • 3张敦熔.耐药性的流行病学意义[J].中国防痨杂志,1997,4:155-155.
  • 4Bashar M, Alcabes P, Rom WN, et al. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service[J], Chest, 2001,120(5):1514-1519.
  • 5Githui WA, Hawken MP, Juma ES, et al. Surveillance of drug-resistant tuberculosis and molecular evaluation of transmission of resistant strains in refugee and non-refugee populations in North-Eastern Kenya[J]. Int J Tuberc Lung Dis, 2000,4(10):947-55.
  • 6Loddenkemper R,Sagebiel D,Brendel. A Strategies against multidrug-resistant tuburculosis[J].Eur Respir J Suppl, 2002,36:66-77.
  • 7Telzak EE, Chirgwin KD, Nelson ET, et al. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and respones to specific drug regimens. terry beirn comminity programs for clinical researc on AIDS (CPCRA) and the AIDS clinical trials group (ACIG), National institutes for health[J]. Int J Tuberc Lung Dis,1999,3(4):337-343..
  • 8Sharma SK, Turaga KK, Balamurrugan A. et al. Clinical and genetic risk factors for the developme multi-drug resistant tuberculosis in non-HIV infect patients at a tertiary care center in India: a case study[J]. Infect genet evol, 2003,3(3):183-1887.
  • 9Zhao Y, Xu S, Wang L, et al. National survey of drug resist-ant tuberculosis in China. N Engl J Med, 2012, 366 (23): 2161- 2170.
  • 10Barrera L. Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs [M/OL]. Gene va:WHO, 2008[2012-06-01]. www. who. int/entity/tb/pub lications/2008/whohtmtb_2008_392/en/-22k.

共引文献297

同被引文献12

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部